1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60DC0360598F59649852577AC00714182
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/corporate-affairs-organizational-structure-best-practices?opendocument
18
19opendocument
2018.212.83.37
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Quality, Compliance and Regulatory Corporate Affairs

Corporate Affairs Excellence: Optimizing Group Structure

ID: 5100


Features:

9 Info Graphics

9 Data Graphics

40 Metrics


Pages/Slides: 38


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Corporate Affairs Excellence: Optimizing Group Structure"

STUDY OVERVIEW
The Corporate Affairs function is important to any biopharmaceutical company's economic health and survival in a competitive marketplace. The function has a wide-ranging role, from building company reputation/brand and communicating to both internal and external stakeholders to building advocacy group relationships and monitoring federal/state lawmaking bodies. While the different groups that make up Corporate Affairs (also defined as Public Affairs in this research project) vary across organizations, they often incude: Policy, Government Affairs, Internal Communications, External Communications and Patient Advocacy.

This study provides benchmarks to identify key Corporate Affairs structural approaches and reporting relationships. In addition, the research delivers many examples of organizational approaches for corporate/public affairs based on research participants' survey data. Corporate Affairs leaders can use this research to compare their organizational structure with those of leading organizations.

SAMPLE KEY TOPICS

  • Corporate Affairs Structures Marked by Diversity
  • Reporting Relationships in Corporate Affairs
  • Corporate Affairs Group Models and Structures
  • Groups that Reside in Corporate Affairs

SAMPLE KEY METRICS
  • Do you use a business unit structure
  • Organizing factors influencing business units commercial structure
  • Job title of Corporate Affairs group head
  • Level that Corporate Affairs Head reports to
  • Approaches best describing company's Corporate Affairs group structure
  • Functions that report to Corporate Affairs head

SAMPLE KEY FINDINGS

Corporate Commercial Structure Evolution: Hybrid structures were the most commonly described commercial structures -- with nearly one-third of companies evolving eclectically to reflect various characteristics designed to help them deal with growing size, scale and geographic complexity. Interestingly, 47% of respondents revealed they had evolved using many diverse forms of decentralization. Many hybrid models also seek to preserve some forms of decentralization to support entrepreneurism at the local level.

METHODOLOGY

This benchmarking research included 28 corporate affairs executives and managers at 27 leading bio-pharmaceutical, healthcare and non-healthcare companies. Field interviews and study analysis produced many observations and benchmark findings.

Industries Profiled:
Health Care; Pharmaceutical; Biotech; Chemical; Utilities; Medical Device; Insurance; Transportation


Companies Profiled:
Genomic Health; MDS Nordion; GlaxoSmithKline; Genentech; Abbott Laboratories; Boehringer Ingelheim; Astellas; National Grid; AstraZeneca Pharmaceuticals; Roche; Stiefel; MSD; MetLife; Lilly; Purdue Pharma; Grace; Intas; Medtronic; Emirates Group; ConvaTec; Eisai; Genzyme; Pfizer; DRI; Merck; Solvay Pharmaceuticals


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.